Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -2.22%67.980.0%$2165.55m
NVAXNovavax, Inc. 7.89%134.2396.5%$1107.73m
SRNESorrento Therapeutics, Inc. 5.01%13.031.5%$767.74m
GILDGilead Sciences, Inc. -0.92%68.211.0%$566.18m
AMGNAmgen, Inc. -0.43%240.691.3%$483.06m
REGNRegeneron Pharmaceuticals, Inc. -0.19%611.202.7%$398.45m
VRTXVertex Pharmaceuticals, Inc. -0.73%268.871.9%$364.75m
BNTXBioNTech SE 3.10%71.260.0%$361.78m
BIIBBiogen, Inc. -1.70%288.251.6%$349.52m
ILMNIllumina, Inc. 3.27%355.383.5%$349.37m
VXRTVaxart, Inc. -1.58%9.060.0%$258.53m
ATNMActinium Pharmaceuticals, Inc. 4.45%9.9813.3%$240.55m
EBSEmergent BioSolutions, Inc. 4.20%135.016.4%$195.98m
MCRBSeres Therapeutics, Inc. 22.41%28.843.6%$166.73m
ALXNAlexion Pharmaceuticals, Inc. -0.87%101.892.0%$166.39m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.